Please Wait
Applying Filters...
menu
    • menu
    CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Spectinomycin Dihydrochloride, Pharmacia

    ACTIVE PHARMA INGREDIENTS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 68Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    31/03/2026 Hebei Shengxue Dacheng Pharmaceutical
    China
    		 Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. Shijiazhuang City CN CEP 2018-152 - Rev 01 Spectinomycin dihydrochloride pentahydrate 2024-10-30 Valid Chemical 1152
    31/03/2026 Shandong Lukang Pharmaceutical Co., Ltd
    China
    		 SHANDONG LUKANG PHARMACEUTICAL CO., LTD. Jining City CN CEP 2004-166 - Rev 04 Spectinomycin dihydrochloride pentahydrate 2024-07-19 Valid Chemical 1152
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.